Heart Clinical Trials

At Genesis Heart Institute, you may get an opportunity to enroll in a clinical trial that tests the safety and effectiveness of a new cardiovascular therapy. In the Quad Cities, you’ll find this option at the Heart Institute because we emphasize innovation so we can better help patients. If you’re interested in a clinical trial, ask your doctor about whether it’s right for you. We’ll help you explore all your treatment possibilities.

Participating in Clinical Trials

To help determine whether you’re eligible for a certain clinical trial, a health care professional will review your medical history. You also may need to receive health screenings, including blood and urine analysis. Your age, sex, previous treatments, type and stage of disease, and other health conditions could affect your eligibility.

If you qualify for a clinical trial, you can choose whether to take part. By enrolling, you’ll gain access to a promising treatment that’s not widely available, and you’ll contribute to medical research that may benefit other patients. But it’s important to remember that your condition may or may not improve during the study. And, like established therapies, new drugs or procedures may cause side effects.

Talk to your physician to make sure you fully understand what the clinical trial would involve. Even if you decide to take part, you may leave the study at any time.

Current Heart & Vascular Clinical Trials

Find cardiovascular clinical trials at Genesis that are now enrolling participants. Learn more about the Genesis Research Program here.

Showing 1-9 of 9

Sorted By:

  • Adherent Sleep Apnea Patients

    The purpose of this study is to categorize sleep apnea patients based on their reason for sleep study referral and their level of adherence, and examine whether this categorization has an effect on key health outcomes.

  • BEST-CLI Trial

    The purpose of the study is to learn about which therapy is more suitable for those patients who are candidates for both open surgery and endovascular treatment, and to provide information regarding cost effectiveness of the two different types of treatment.

  • CardioMEMS

    The purpose of this study is to show that data collected about the use of the CardioMEMS HF System in patient care are similar with data collected in a controlled clinical study. This study will be done at up to 150 clinical sites in the United States (US). There will be 1,200 patients included in the study.

  • COPPER-A

    The purpose of this research study is to determine if the use of a catheter for the delivery of paclitaxel will prevent re-narrowing of a blockage to be treated in the leg.

  • ISCHEMIA

    The ISCHEMIA study compares two standard treatments for ischemia of the heart to learn which one is better. Ischemia of the heart occurs when there is decreased blood flow due to narrowing in one or more of the heart arteries because of the buildup of cholesterol.

  • MERCURY PE

    The purpose of this study is to compare the effects (both good and bad) of rivaroxaban to those of the local standard of care at the hospital for patients who have been diagnosed with a blood clot to/from their lung, called a pulmonary embolism (PE).

  • Psychology Research: Impact of Therapy Dogs

    The purpose of this study is to see if therapy dogs can help family members of surgical or cardiac patients feel less worried or stressed.

  • VERNACULAR

    The purpose of this study is to evaluate the safety and effectiveness of the VENOVO ™ Venous Stent.

  • VIRTUS

    The purpose of this study is to evaluate the safety and effectiveness of the Veniti Vici Venous Stent System.

Showing trials 1-9 of 9

Contact Us

Your Question Deserves an Answer

We are here to answer your questions and address your concerns. Fill out our quick "contact us" form or call 563-421-3900 and we'll get back to you ASAP.

CONTACT US NOW

Starting Again with TAVR

Bonnie Morris, TAVR patient

Bonnie Morris knows what it means to have surgery: she's had her left lung removed, heart bypass surgery and the placement of a pacemaker. But after being diagnosed with severe aortic stenosis, Mrs. Morris didn't find relief through a complex, open-chest surgery--she had TAVR.

Read Her Story

Related Locations